154 related articles for article (PubMed ID: 1724531)
1. Effects of nifedipine on global myocardial ischemic injury in hearts from diabetic and age-matched control rats.
Heijnis JB; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1991 Oct; 18(4):542-7. PubMed ID: 1724531
[TBL] [Abstract][Full Text] [Related]
2. The blood contribution to early myocardial reperfusion injury is amplified in diabetes.
McDonagh PF; Hokama JY; Copeland JG; Reynolds JM
Diabetes; 1997 Nov; 46(11):1859-67. PubMed ID: 9356037
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
Hoff PT; Tamura Y; Lucchesi BR
Am J Cardiol; 1989 Nov; 64(17):101I-115I discussion 115I-116I. PubMed ID: 2530882
[TBL] [Abstract][Full Text] [Related]
4. Antiischemic effects of nifedipine in isolated working heart preparations of healthy, diabetic, and hypertensive rats.
Pijl AJ; Hendriks MG; Kam KL; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 1994 Mar; 23(3):379-86. PubMed ID: 7515980
[TBL] [Abstract][Full Text] [Related]
5. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
Becker BF; Möbert J
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines.
Liu X; Engelman RM; Wei Z; Bagchi D; Rousou JA; Nath D; Das DK
Biochem Pharmacol; 1993 Mar; 45(6):1333-41. PubMed ID: 8466553
[TBL] [Abstract][Full Text] [Related]
7. Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats.
Heijnis JB; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1991 Jun; 17(6):983-9. PubMed ID: 1714025
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury.
Moon CH; Jung YS; Lee SH; Baik EJ
Jpn J Physiol; 1999 Oct; 49(5):409-15. PubMed ID: 10603424
[TBL] [Abstract][Full Text] [Related]
9. Insulin worsens ischemia-induced myocardial contracture in the isolated rat heart.
Pretto E; Schaible T; Scheuer J; Safar P; Stezoski SW
Crit Care Med; 1986 Jun; 14(6):555-9. PubMed ID: 3519078
[TBL] [Abstract][Full Text] [Related]
10. Effect of inosine in the normal and reperfused rat heart.
Powers FM; Sobotka PA; Thomas JX
J Cardiovasc Pharmacol; 1990 Jun; 15(6):862-7. PubMed ID: 1694907
[TBL] [Abstract][Full Text] [Related]
11. Experimental conditions determine effects of ascorbic acid on reperfusion injury: comparison of tissue damage with hemodynamic parameters in rat isolated hearts.
Doppelfeld IS; Parnham MJ
Methods Find Exp Clin Pharmacol; 1992; 14(6):419-30. PubMed ID: 1469951
[TBL] [Abstract][Full Text] [Related]
12. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic "stunned" myocardium.
Przyklenk K; Ghafari GB; Eitzman DT; Kloner RA
J Am Coll Cardiol; 1989 Apr; 13(5):1176-83. PubMed ID: 2926068
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonists show two modes of protection in ischemic heart failure.
van Amsterdam FT; Punt NC; Haas M; Zaagsma J
J Pharmacol Exp Ther; 1990 Apr; 253(1):277-83. PubMed ID: 2329511
[TBL] [Abstract][Full Text] [Related]
14. Dichotomy in the post-ischemic metabolic and functional recovery profiles of isolated blood-versus buffer-perfused heart.
Galiñanes M; Bernocchi P; Argano V; Cargnoni A; Ferrari R; Hearse DJ
J Mol Cell Cardiol; 1996 Mar; 28(3):531-9. PubMed ID: 9011636
[TBL] [Abstract][Full Text] [Related]
15. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
Illing B; Horn M; Han H; Hahn S; Bureik P; Ertl G; Neubauer S
J Cardiovasc Pharmacol; 1996 Apr; 27(4):487-94. PubMed ID: 8847864
[TBL] [Abstract][Full Text] [Related]
17. Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts.
Boucher FR; Hearse DJ; Opie LH
J Cardiovasc Pharmacol; 1994 Jul; 24(1):45-9. PubMed ID: 7521488
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection by nifedipine in isolated working hearts: a comparative study on three different types of experimental ischemia.
Pijl AJ; Pfaffendorf M; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1993 Jan; 21(1):70-6. PubMed ID: 7678682
[TBL] [Abstract][Full Text] [Related]
19. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning in globally ischemic isolated rat hearts: effect on function and metabolic indices of myocardial damage.
Arad M; de Jong JW; de Jonge R; Huizer T; Rabinowitz B
J Mol Cell Cardiol; 1996 Dec; 28(12):2479-90. PubMed ID: 9004164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
